Form 8-K - Current report:
SEC Accession No. 0000939767-24-000138
Filing Date
2024-10-15
Accepted
2024-10-15 08:00:17
Documents
14
Period of Report
2024-10-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K exel-20241014.htm   iXBRL 8-K 23603
5 exel-20241014_g1.jpg GRAPHIC 55431
  Complete submission text file 0000939767-24-000138.txt   281777

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20241014.xsd EX-101.SCH 1917
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20241014_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20241014_pre.xml EX-101.PRE 12522
16 EXTRACTED XBRL INSTANCE DOCUMENT exel-20241014_htm.xml XML 2709
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0103
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 241369338
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)